Charles Zhu
Stock Analyst at LifeSci Capital
(4.84)
# 418
Out of 5,020 analysts
309
Total ratings
59.8%
Success rate
22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterated: Buy | $40 | $21.51 | +85.96% | 21 | Sep 30, 2026 | |
| ADAG Adagene | Reiterated: Buy | $8 | $3.20 | +150.00% | 11 | Sep 29, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $315 | $205.26 | +53.46% | 35 | Sep 28, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $34 | $26.49 | +28.35% | 30 | Sep 28, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $38.42 | +50.96% | 59 | Sep 27, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $46 | $25.83 | +78.09% | 6 | Sep 27, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $1.04 | - | 14 | Sep 22, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $32 | $18.64 | +71.67% | 2 | Sep 15, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $12 | $3.91 | +206.91% | 20 | Aug 25, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $28 | $10.71 | +161.44% | 34 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $32.29 | +30.07% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $16.11 | +235.20% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $3.05 | +555.74% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.3004 | +565.78% | 8 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $14.59 | +91.91% | 11 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $7.33 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $24.95 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $20 | $3.86 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $32.02 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $39 | $24.95 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.5938 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.82 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $20 | $1.67 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.39 | n/a | 1 | Nov 29, 2022 |
Immunome
Sep 30, 2026
Reiterated: Buy
Price Target: $40
Current: $21.51
Upside: +85.96%
Adagene
Sep 29, 2026
Reiterated: Buy
Price Target: $8
Current: $3.20
Upside: +150.00%
Revolution Medicines
Sep 28, 2026
Reiterated: Buy
Price Target: $315
Current: $205.26
Upside: +53.46%
Zymeworks
Sep 28, 2026
Reiterated: Buy
Price Target: $34
Current: $26.49
Upside: +28.35%
IDEAYA Biosciences
Sep 27, 2026
Reiterated: Buy
Price Target: $58
Current: $38.42
Upside: +50.96%
Arcus Biosciences
Sep 27, 2026
Reiterated: Buy
Price Target: $46
Current: $25.83
Upside: +78.09%
Compass Therapeutics
Sep 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.04
Upside: -
BlossomHill Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $18.64
Upside: +71.67%
Molecular Partners AG
Aug 25, 2026
Reiterated: Buy
Price Target: $12
Current: $3.91
Upside: +206.91%
Kura Oncology
Aug 13, 2026
Reiterated: Buy
Price Target: $28
Current: $10.71
Upside: +161.44%
Aug 13, 2026
Reiterated: Buy
Price Target: $42
Current: $32.29
Upside: +30.07%
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $16.11
Upside: +235.20%
Aug 11, 2026
Rated: Buy
Price Target: $26 → $20
Current: $3.05
Upside: +555.74%
Aug 8, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $0.3004
Upside: +565.78%
Jul 30, 2026
Reiterated: Buy
Price Target: $28
Current: $14.59
Upside: +91.91%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $7.33
Upside: n/a
May 24, 2024
Reiterated: Buy
Price Target: $14
Current: $24.95
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: $12 → $20
Current: $3.86
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $32.02
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: $45 → $39
Current: $24.95
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $5
Current: $0.5938
Upside: n/a
Jan 3, 2023
Reiterated: Hold
Price Target: n/a
Current: $27.82
Upside: n/a
Jan 3, 2023
Reiterated: Buy
Price Target: $30 → $20
Current: $1.67
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.39
Upside: n/a